Watson Pharmaceuticals, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for net income of $1.60 per share, a rise of 79.8% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from $1.53. Between one and three months ago, the average estimate moved up. It has risen from $1.58 during the last month. For the year, analysts are projecting profit of $5.75 per share, a rise of 20.5% from last year.
Past Earnings Performance: Last quarter, the company beat estimates by 2 cents, coming in at net income of $1.77 a share versus the estimate of profit of $1.75 a share. It marked the fourth straight quarter of beating estimates.
Investing Insights: What’s the Future of Microsoft’s Stock?
Wall St. Revenue Expectations: Analysts are projecting a rise of 68.9% in revenue from the year-earlier quarter to $1.48 billion.
Analyst Ratings: Analysts are high on the stock, with 16 analysts rating it as a buy, none rating it as a sell and five rating it as a hold.
A Look Back: In the fourth quarter of the last fiscal year, profit rose more than fivefold to $94.8 million (75 cents a share) from $18.3 million (14 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 62.1% to $1.54 billion from $952.7 million.
Key Stats:
On the top line, the company is looking to build on four-straight revenue increases heading into this earnings announcement. Revenue rose 2.3% in the first quarter of the last fiscal year, 23.6% in the second quarter of the last fiscal year and 22.6% in the third quarter of the last fiscal year before increasing again in the fourth quarter of the last fiscal year of the last fiscal year.
There has enjoyed solid performance recently heading into this earnings announcement with profit rising by a year-over-year average of more than twofold for the last four quarters.
Stock Price Performance: Between February 27, 2012 and April 24, 2012, the stock price had risen $10.66 (18.4%), from $57.94 to $68.60. The stock price saw one of its best stretches over the last year between September 12, 2011 and September 20, 2011, when shares rose for seven straight days, increasing 9.6% (+$6.31) over that span. It saw one of its worst periods between July 22, 2011 and August 2, 2011 when shares fell for eight straight days, dropping 8% (-$5.67) over that span.
For the latest updates on the stock market, PRESS CTR + D or visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today
No comments:
Post a Comment